Open AccessAnti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes
Author(s) -
Carmine Gazzaruso,
Adriana Coppola,
Tiziana Montalcini,
Colomba Falcone
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.03.30
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , disease , risk factor , type 2 diabetes mellitus , endocrinology , cardiology
Type 2 diabetes mellitus is a powerful cardiovascular (CV) risk factor (1). Diabetic patients have a 2- to 4-times increased CV risk and about 80% of them die from CV disease (CVD) (1-3).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom